Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On May 6, 2020, the Board of Directors (the "Board") of ScanSource, Inc. (the
"Company") increased the size of its Board to eight members and appointed
Jeffrey R. Rodek as a director of the Company, both effective May 6, 2020.
Mr. Rodek was also appointed to serve on the Audit, Compensation, Governance,
Nominating and Risk Committees of the Board.
Mr. Rodek, age 66, has served as an Executive Network Advisor and Limited
Partner of Tensility Venture Partners, a seed-stage venture capital firm
investing in enterprise software companies, since October 2017. From July 2007
to May 2018, Mr. Rodek served as a Senior Lecturer at the Fisher College of
Business at The Ohio State University. Prior to that, Mr. Rodek served as Senior
Advisor and Executive Partner at Accretive, LLC from July 2007 to December 2009;
as Executive Chairman, Chairman and Chief Executive Officer of Hyperion
Solutions Corporation from October 1999 to April 2007; and as President and
Chief Operating Officer of Ingram Micro Corporation from 1995 to 1999.
Mr. Rodek has over 40 years of business and leadership experience spanning
across multiple industries. Over Mr. Rodek's career, he has driven performance
growth and improved corporate governance strategies in the enterprise software
and technology solutions industries, giving him a keen understanding of the
challenges and issues present in the Company's industry.
Upon his appointment to the Board, Mr. Rodek became entitled to a prorated
portion of the non-employee directors' compensation. To that end, Mr. Rodek is
entitled to receive a prorated portion of the annual retainer of $85,000.
Mr. Rodek will also be entitled to reimbursement of his expenses incurred in
connection with the performance of his services as a director.
In addition, Mr. Rodek will receive annual awards of restricted stock units
under the Company's 2013 Long-Term Incentive Plan (the "2013 Plan"). Each
non-employee director of the Company annually receives an award of restricted
stock units, determined by dividing $130,000 by the Equity Award Value (as
defined in the 2013 Plan). Because Mr. Rodek first became a non-employee
director on a date other than the regularly scheduled annual equity grant, he
will receive an award for a prorated number of restricted stock units. The
restricted stock units are granted automatically under the 2013 Plan and may not
be transferred or sold until vested. Restricted stock units granted under the
2013 Plan will vest in full on the day that is six months after the date of
grant, or upon the earlier to occur of (i) the director's termination of service
as a director by reason of death, disability or retirement, or (ii) a change in
control of the Company. If Mr. Rodek terminates his service as a director for
any other reason, he will forfeit all of his right, title and interest in and to
the restricted stock as of the date of termination.
There are no transactions between Mr. Rodek or any member of his immediate
family and the Company or any of its subsidiaries and there is no arrangement or
understanding between Mr. Rodek and any other persons or entities pursuant to
which Mr. Rodek was appointed as a director of the Company.
The full text of the press release announcing Mr. Rodek's appointment is
furnished as Exhibit 99.1 to this Current Report on Form 8-K and shall not be
deemed "filed" for purposes of Section 18 of the Securities Exchange Act of
1934, as amended, or otherwise subject to the liabilities of that Section.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit
Number Description
99.1 Press Release.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document).
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses